| Q44783961 | A truncated kringle domain of human apolipoprotein(a) inhibits the activation of extracellular signal-regulated kinase 1 and 2 through a tyrosine phosphatase-dependent pathway |
| Q38777200 | Adiponectin induces CXCL1 secretion from cancer cells and promotes tumor angiogenesis by inducing stromal fibroblast senescence |
| Q36602451 | Adiponectin-induced antiangiogenesis and antitumor activity involve caspase-mediated endothelial cell apoptosis. |
| Q73119139 | Angiogenesis in hematologic malignancies |
| Q35146591 | Angiogenesis, lymphangiogenesis, and melanoma metastasis |
| Q36306264 | Angiogenic inhibitors: a new therapeutic strategy in oncology |
| Q33222336 | Angiostatin inhibits pancreatic cancer cell proliferation and growth in nude mice |
| Q57190016 | Antiangiogenic mechanisms of diet-derived polyphenols |
| Q34339335 | Antitumor activity of pyrvinium pamoate, 6-(dimethylamino)-2-[2-(2,5-dimethyl-1-phenyl-1H-pyrrol-3-yl)ethenyl]-1-methyl-quinolinium pamoate salt, showing preferential cytotoxicity during glucose starvation |
| Q34664957 | Blocking ovarian cancer progression by targeting tumor microenvironmental leukocytes |
| Q48049656 | Collateral Damage Intended-Cancer-Associated Fibroblasts and Vasculature Are Potential Targets in Cancer Therapy. |
| Q33264491 | Display technologies: application for the discovery of drug and gene delivery agents |
| Q35237543 | Effects of Alpha Particle and Proton Beam Irradiation as Putative Cross-Talk between A549 Cancer Cells and the Endothelial Cells in a Co-Culture System |
| Q81042724 | Endogenous angiogenin in endothelial cells is a general requirement for cell proliferation and angiogenesis |
| Q81416638 | Expression of vascular endothelial growth factor-A, matrix metalloproteinase-9, and extravascular matrix patterns and their correlations with clinicopathologic parameters in posterior uveal melanomas |
| Q36835748 | Geometric control of vascular networks to enhance engineered tissue integration and function |
| Q38007880 | HIF-mediated endothelial response during cancer progression. |
| Q38501776 | Integrin-mediated cell-matrix interaction in physiological and pathological blood vessel formation |
| Q37150405 | Intermittent hypoxia is a key regulator of cancer cell and endothelial cell interplay in tumours |
| Q43776835 | Marine algal carotenoids inhibit angiogenesis by down-regulating FGF-2-mediated intracellular signals in vascular endothelial cells. |
| Q37213612 | Molecular mechanisms and therapeutic development of angiogenesis inhibitors |
| Q47363128 | Molecular medicine: the writing is on the vessel wall |
| Q48323799 | Oroxyloside inhibits angiogenesis through suppressing internalization of VEGFR2/Flk-1 in endothelial cells. |
| Q33942544 | Solid-tumor radionuclide therapy dosimetry: new paradigms in view of tumor microenvironment and angiogenesis |
| Q36078034 | The role of dendritic cell precursors in tumour vasculogenesis. |
| Q36409381 | Tumor angiogenesis and therapy |
| Q30455612 | Vascular endothelial growth factor as an anti-angiogenic target for cancer therapy |
Search more.